You are here:
Gavi’s two funding streams, innovative finance and direct contributions account for 31% and 69% respectively of the Vaccine Alliance’s overall funding portfolio.
Multi-year pledges and commitments are crucial to sustaining Gavi's ongoing programmes and its ability to fund new vaccines.
Public-private partnerships Corporations, private individuals & foundations play a vital role in meeting Gavi needs, accounting for 23% of 2000 to 2014 funding.
Cultivation of key public & private donor relationships, co-financing, shaping vaccine markets and mobilising civil society advocacy.
Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.
19 February 2015
27 January 2015
Donors pledge record $7.5B for global vaccines program
The Daily Mail
22 January 2015
A Birthday Gift to Last a Lifetime
The Huffington Post
11 January 2015
The United States should generously support Gavi's immunization efforts
The Washington Post
06 January 2015
Gates Foundation Uses Art to Encourage Vaccination
The New York Times
18 December 2014
A global conspiracy of health
05 December 2014
Ebola Vaccines: Why Clinical Trials Are Just the First Step
04 December 2014
An Important Step in Congress for Protecting Children’s Health
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2015
modal window here